Home › Non-Small Cell Lung Cancer › Minnesota › Brooklyn Park
Non-Small Cell Lung Cancer clinical trials in Brooklyn Park, MN
10 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Brooklyn Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Mercy Hospital, Coon Rapids · 4 mi away
- North Memorial Medical Health Center, Robbinsdale · 4 mi away
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Mercy Hospital, Coon Rapids · 4 mi away
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- Allina Health Cancer Institute - Mercy Hospital, Coon Rapids · 4 mi away
- Minnesota Oncology Hematology, PA, Coon Rapids · 4 mi away
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Allina Health Cancer Institute - Mercy Hospital, Coon Rapids · 4 mi away
- Minnesota Oncology Hematology, P.A., Coon Rapids · 4 mi away
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecruitingPhase 3
- Minnesota Oncology Hematology PA, Coon Rapids · 4 mi away
- North Memorial Health Cancer Center, Robbinsdale · 4 mi away
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RecruitingPhase 2
- Mercy Hospital, Coon Rapids · 4 mi away
- Minnesota Oncology - Coon Rapids, Coon Rapids · 4 mi away
- North Memorial Medical Health Center, Robbinsdale · 4 mi away
- and 2 more
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Allina Health Cancer Institute - Mercy Hospital, Coon Rapids · 4 mi away
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Mercy Hospital, Coon Rapids · 4 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Mercy Hospital, Coon Rapids · 4 mi away
- North Memorial Medical Health Center, Robbinsdale · 4 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Mercy Hospital, Coon Rapids · 4 mi away
- North Memorial Medical Health Center, Robbinsdale · 4 mi away
- Monticello Cancer Center, Monticello · 26 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Brooklyn Park
- Lung Cancer10 studies
- Colorectal Cancer7 studies
- Prostate Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Breast Cancer6 studies
- Endometrial Cancer5 studies
- Melanoma5 studies
- Ovarian Cancer4 studies
- Colon Cancer4 studies
- Chronic Lymphocytic Leukemia4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.